People with a circulation condition called Primary Raynaud’s are being asked to help researchers at the University of Nottingham find out whether antioxidant compounds in cocoa can help alleviate symptoms.
Raynaud’s is a circulatory condition in which the small blood vessels in the fingers or toes constrict in response to the cold. It can be distressing as the fingers or toes turn cold, white and numb, followed by discomfort when the fingers turn blue and then a red hot flush upon rewarming.
Primary Raynaud’s is thought to affect up to 10 million people in the UK and can be difficult to manage and treat. The exact cause of the condition is unknown and women are more commonly affected than men.
The research team at the University’s School of Life Sciences are looking for otherwise healthy volunteers with Primary Raynaud’s to help them examine the effects of antioxidant compounds known as flavanols that are found in cocoa.
Leading the research, Professor of Metabolic Physiology, Ian MacDonald, said: “Previous studies in healthy people have shown an improvement in blood flow and blood pressure after consumption of cocoa flavanols so we want to test this in a group of younger individuals with Primary Raynaud’s. We are setting out to assess the longer term effects of cocoa on symptom severity and the prevalence of symptoms in people with Raynaud’s.”
The researchers need to recruit around 60 healthy people aged between 18 and 60 who report symptoms of Raynaud’s to take part in the study. The participants will have a simple medical screening for heart rate, blood pressure, height and weight. Over the course of three months the participants will be asked to consume four capsules (containing either cocoa or placebo ) per day and attend the Medical School at the beginning and end of the 3 months to have the temperature regulation of their right hand assessed.
The information recorded by the research team will be anonymised before it is published and will help them to design future studies aimed at helping people with Primary Raynaud’s. The researchers are keen to hear from any individuals with Primary Raynaud’s symptoms in the recruitment age range who are interested in taking part in the study via the contacts below.
The trial website is available here.
— Ends —
Our academics can now be interviewed for broadcast via our Media Hub, which offers a Globelynx fixed camera and ISDN line facilities at University Park campus. For further information please contact a member of the Communications team on +44 (0)115 951 5798, email firstname.lastname@example.org or see the Globelynx website for how to register for this service.
For up to the minute media alerts, follow us on Twitter
Notes to editors:
The University of Nottingham is a research-intensive university with a proud heritage, consistently ranked among the world's top 100. Studying at the University of Nottingham is a life-changing experience and we pride ourselves on unlocking the potential of our 44,000 students - Nottingham was named both Sports and International University of the Year in the 2019 Times and Sunday Times Good University Guide, was awarded gold in the TEF 2017 and features in the top 20 of all three major UK rankings. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement. We are ranked eighth for research power in the UK according to REF 2014. We have six beacons of research excellence helping to transform lives and change the world; we are also a major employer and industry partner - locally and globally.
Impact: The Nottingham Campaign, its biggest-ever fundraising campaign, is delivering the University’s vision to change lives, tackle global issues and shape the future. More news…